Keyphrases
Trypanosoma Brucei
100%
Mycobacterium Tuberculosis (M. tb)
99%
Human African Trypanosomiasis
80%
T. Brucei
48%
N-myristoyltransferase
44%
Phenotypic Screening
33%
Antitrypanosomal Activity
33%
N-Myristoyltransferase Inhibitors
33%
Protein Kinase
33%
Drug Target
31%
Pharmacokinetic Properties
27%
QcrB
24%
Lead Molecules
22%
Diaminothiazoles
22%
Mouse Model
22%
Cytochrome c Oxidase
22%
Tuberculosis
22%
Resistant Strains
20%
New Drugs
19%
Oral Drugs
17%
Molecular Targets
17%
Tuberculosis Drugs
16%
Off-target Effects
16%
Respiratory Flexibility
16%
Bc1 Complex
16%
Cytotoxicity Profile
16%
Spirocycles
16%
MmpL3 Inhibitor
16%
CRK3
16%
Cdc2
16%
Visceral Leishmaniasis
16%
Prolyl-tRNA
16%
Peptidyl-tRNA Hydrolase
16%
Sleeping Sickness
16%
New Leads
16%
U50,488
16%
Pyrazolo
16%
Opioid Agonist
16%
Sulfonamide Antibiotics
16%
LysR Family
16%
Preclinical Development
16%
GSK-3 Inhibitors
16%
Indole-2
16%
Carboxamide Derivatives
16%
Drug Discovery
16%
Trypanothione Reductase
16%
Morpholino
16%
Brain Penetrant
16%
Gene Profile
16%
Imidazo
16%
Pharmacology, Toxicology and Pharmaceutical Science
Trypanosoma Brucei
95%
African Trypanosomiasis
87%
Mycobacterium Tuberculosis
58%
Protein Kinases
38%
Hexachlorophene
35%
Pharmacokinetics
33%
Sulfonamide
33%
Mouse Model
24%
Tuberculosis
24%
Cytotoxicity
24%
Structure Activity Relationship
22%
Disease
21%
Phosphotransferase
17%
Infection
17%
Target Activity
16%
Drug Discovery
16%
Lysine Transfer RNA Ligase
16%
Carboxamide
16%
Visceral Leishmaniasis
16%
Trypanothione Reductase
16%
3,4 Dichloro N Methyl N [2 (1 Pyrrolidinyl)cyclohexyl]benzeneacetamide
16%
Opiate Agonist
16%
Pyrazole
16%
Antiproliferative Activity
16%
Ion Channel
16%
Leishmania
16%
Indazole Derivative
16%
Inosinate Dehydrogenase
16%
Transferase Inhibitor
16%
Lead Compound
14%
Molecular Target
12%
EC50
11%
Phenazone
9%
Parasitosis
9%
Zwitterion
8%
Cytochrome C
8%
Thiophene
8%
Oxidoreductase
8%
Cytochrome C Oxidase
8%
Trypanosoma
8%
Isotopes of Potassium
8%
High-Throughput Screening
7%
Cytostatic Agent
6%
Guanine
6%
Tolerability
5%
Cycline
5%
Cyclin Dependent Kinase
5%
Trypanosoma Brucei Brucei
5%
IC50
5%
Protozoon
5%
